CLINICAL AND ECONOMIC IMPACT OF THE USE OF INFLIXIMAB BIOSIMILAR INFLECTRA IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHROPATHY AND ANKYLOSING SPONDYLITIS PATIENTS
Author(s)
Borras Blasco J1, Gracia-Pérez A2, Casterá D1, Rosique-Robles, D1, Abad J1, Heskouri Benlemlih H1
1Hospital Sagunto, Sagunto, Spain, 2Hospital de Sagunto, Sagunto, Spain
OBJECTIVES: The aim of this study is determine the persistence, clinic and economic impact of the use of Inflectra®in Rheumatoid arthritis (RA), psoriatic arthritis (PA) and ankylosing spondylitis (AS) patients METHODS: Observational, retrospective cohort study patients treated with Inflectra® during Jun 2015 to June 2016. We collected age, sex, indication, dose and persistence of Inflectra®
Conference/Value in Health Info
2016-10, ISPOR Europe 2016, Vienna, Austria
Value in Health, Vol. 19, No. 7 (November 2016)
Code
PMS86
Topic
Health Service Delivery & Process of Care
Topic Subcategory
Prescribing Behavior, Treatment Patterns and Guidelines
Disease
Musculoskeletal Disorders
Your browser is out-of-date
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now